Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Alpharma expects to eliminate debt by January 2006: DHPI, ALO, PRH, USNA.
- M2 PRESSWIRE-30 December 2005-SessionsIR.com: Alpharma expects to eliminate debt by January 2006: DHPI, ALO, PRH, USNAC1994-2005 M2 COMMUNICATIONS LTD RDATE:30122005 Stocks in the News: Desert Health Products International Incorporated (OTC: DHPI), Alpharma Incorporated (NYSE: ALO), Vitacube Systems Holdings Incorporated (AMEX:...
- Research articles 2005-12-30
- Schaeffer's Midday Options Update Features Alpharma, Intel, Ford Motor, Sprint and Caterpillar
- CINCINNATI -- Today's Schaeffer's Midday Options Update features Alpharma (NYSE:ALO), Intel (NASDAQ:INTC), Ford Motor (NYSE:F), Sprint (NYSE:FON) and Caterpillar (NYSE:CAT). The Midday Options Update contains a brief commentary on the day's most notable activity and a table listing the most-active calls and puts for the day. The Midday Options...
- Research articles 2005-04-20
- Getting poised for a steeper growth curve
- New YORK -- The winds of change have begun to fill the generic drug industry's sails. Driven by expiring patents on big-selling blockbuster drugs and the frantic search for lower-cost prescription alternatives by health plan payers, generic utilization rates have grown roughly 6 percent by volume over the past two...
- Research articles 2003-02-17
- ALPHARMA declares regular quarterly cash dividend
- FORT LEE, N.J.--BUSINESS WIRE--September 22, 1995--ALPHARMA INC. (NYSE:ALO) today announced that its Board of Directors has declared a regular quarterly cash dividend of $.045 per common share.The dividend is payable October 20, 1995 to all shareholders of record as of October 6, 1995.ALPHARMA is a multinational pharmaceutical company developing, manufacturing...
- Research articles 1995-09-22
Additional Resources
- AlPharma's "High-Price Hooker" Strategy May Backfire in King M&A Battle
- In King Pharmaceuticals' allegedly hostile takeover attempt of AlPharma, the target company is utilizing what I like to call the Ashley Dupre pictured strategy: It's saying, Yes, you can have me, but I don't come cheap. I say "allegedly hostile" because AlPharma has made it clear from...
- Blog posts 2008-09-15
- Alpharma Buys Roche's Medicated Feed Additives Business for $300 Million.(Brief Article)
- SEEKING TO FURTHER build its position in animal health, Alpharma Inc. is acquiring Roche's medicated feed additives MFA business for $300 million. Alpharma's acquisition includes all assets, manufacturing and formulation facilities in the U SEEKING TO FURTHER build...
- Research articles 2000-05-01
- Alpharma Inc. (Active Pharmaceutical Ingredient Watch).(reports fourth quarter losses)(Brief Article)(Statistical Data Included)
- ALPHARMA Inc. reported a fourth quarter net loss of $80.2 million compared to net income of $18.7 million in the year-ago period, ... ALPHARMA Inc. reported a fourth quarter net loss of $80.2 million compared to net income of $18.7 million in the year-ago period,...
- Research articles 2002-03-18
- Alpharma to Present at 26th Annual JP Morgan Healthcare Conference
- Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the JP Morgan Healthcare Conference on Wednesday, January 9, 2008 at 7:30 am Pacific Time. The conference will be held at the Westin St. Francis...
- Research articles 2008-01-04
- Alpharma to Present at Merrill Lynch & Co., Inc. Global Pharmaceutical, Biotechnology & Medical Device Conference
- Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Tuesday, February 5, 2008 at 9:20AM Eastern Standard Time. The conference will be held...
- Research articles 2008-01-29
- Alpharma to Present at Morgan Stanley Global Healthcare Unplugged Conference
- Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the Morgan Stanley Global Healthcare Unplugged Conference on Friday, May 2, 2008 at 10:30AM Eastern Daylight Time. The conference will be held at The Ritz...
- Research articles 2008-04-25
- King Pharmaceuticals Responds to Alpharma Inc
- BRISTOL, Tenn. -- King Pharmaceuticals, Inc. (NYSE: KG) today issued the following statement in response to an announcement by Alpharma Inc. (NYSE: ALO) regarding King's offer to acquire Alpharma for $37.00 per share in cash.[TABLE OMITTED] On September 12, 2008, King Pharmaceuticals announced that it commenced a tender...
- Research articles 2008-09-26
- Alpharma to Present at the Roth Capital Partners 20th Annual Growth Conference
- Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that senior management will provide an overview of the company's business at the Roth Capital Partners Growth Conference on Wednesday, February 20, 2008 at 9:30AM Pacific Standard Time. The conference will be held at The Ritz Carlton...
- Research articles 2008-02-12
- ALPHARMA INC.(gets FDA's approval to use Deccox and BMD)
- ALPHARMA INC.'s animal health division has received Food and Drug Administration approval for the combined use of Deccox decoquinate and BMD bacitracin methylene disalicylate in the prevention of coccidiosis in ... ALPHARMA INC.'s animal health division has received Food and Drug Administration approval for the...
- Research articles 1998-09-07
- Alpharma Inc. (Jobs and People).(Brief Article)
- Jeffrey Campbell has been named vice president and controller of Alpharma Inc. Mr. Campbell has more ... Jeffrey Campbell has been named vice president and controller of Alpharma Inc. Mr. Campbell has more than 20 years of experience, spanning both business operations and enterprise-wide...
- Research articles 2002-11-11
- ALPHARMA INC.
- ALPHARMA INC.'s animal health division has received new approval from Food and Drug Administration for the ... ALPHARMA INC.'s animal health division has received new approval from Food and Drug Administration for the combined use of narasin/nicarbazin, roxarsone and bacitracin methylene disalicylate in ...
- Research articles 1999-04-05
- ALPHARMA Inc.(Company Business and Marketing)
- ALPHARMA Inc.'s US pharmaceuticals division has received tentative approval from the Food and Drug Administration to manufacture and market minoxidil topical ... ALPHARMA Inc.'s US pharmaceuticals division has received tentative approval from the Food and Drug Administration to manufacture and market minoxidil topical...
- Research articles 1999-08-16
- Alpharma Opens Office
- ALPHARMA INC.'S animal health division has opened a new office in Verrieres le Buisson, France, to meet the growing demand for its line of animal health and feed additives. The French subsidiary will I be managed by Alain ... ALPHARMA INC.'S animal health division has opened...
- Research articles 1998-05-18
- ALPHARMA Inc.
- ALPHARMA Inc has received approval from Food and Drug Administration for ipratropium bromide ... ALPHARMA Inc has received approval from Food and Drug Administration for ipratropium bromide inhalation solution 0.2 percent, a generic version of Boehringer Ingelheim's Atroventa, a respiratory drug.
- Research articles 1999-05-10
- ALPHARMA.(Animal Health Div. gets FDA approval for chemical use in prevention of coccidiosis in chicken)
- ALPHARMA Inc.'s Animal Health Division has received FDA approval for the combination use of decoquinate (Deccox, 27.2g/ton) plus bacitracin methylene disalicylate (BMD, 4g to 50g/ton) for the ... ALPHARMA Inc.'s Animal Health Division has received FDA approval for the combination use of decoquinate (Deccox, 27.2g/ton)...
- Research articles 1998-08-31
- ALPHARMA Inc.
- ALPHARMA Inc., Fort Lee, N.J., has received new approvals from Food and Drug Administration for its animal health division products. FDA has approved the combined use of Coban (monensin, 90-110 g/ton), 3-Nitro (roxarsone, 22.7-45.4 g/ton) and BMD ( ALPHARMA Inc., Fort Lee, N.J., has...
- Research articles 1999-03-01
- << Previous
- page 1 of 1
- Next >>
